NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton,...

FDA Recall #D-0652-2021 — Class II — July 2, 2021

Recall #D-0652-2021 Date: July 2, 2021 Classification: Class II Status: Terminated

Product Description

NIFEdipine EXTENDED-RELEASE TABLETS, USP 30 mg Rx only packaged as a) 100 count unit dose carton, NDC 0904-7080-61; b) 50 count unit dose carton, NDC 0904-7080-06: Distributed by: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408 Distributed by: Major Pharmaceuticals 17177 N Laurel Park Dr., Suite 233 Livonia, MI 48152 USA

Reason for Recall

Failed Dissolution Specification: Out of specification for dissolution during routine stability testing.

Recalling Firm

The Harvard Drug Group — Livonia, MI

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

504 Cartons of 50 count each; 372 Cartons of 100 count each

Distribution

Distributed in OH and NJ

Code Information

Lots: a)N00418 Exp. 09/2022, b) N00417 Exp. 09/2022

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated